GDTC - CytoMed Therapeutics Limited News

Sectors

GDTC

CytoMed Therapeutics Limited

0.96

1 x 1.00

120 x 1.26

bid

ask

0.01

1.03%

04:00 PM

timesize

Ytd	-28.36%
1y	-52.48%

0.96

day range

0.96

0.68

52 week range

3.68

Open	0.96	Prev Close	0.97	Low	0.96	High	0.96	Mkt Cap	11.48M
Vol	173.00	Avg Vol	18.84K	EPS	-0.22	P/E	-4.49	Forward P/E	-15.80
Beta	0.01	Short Ratio	7.54	Inst. Own	0.04%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	04-28	50-d Avg	1.06	200-d Avg	1.32	1yr Est	5.00

GDTC News

benzinga.com

9 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers American Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-

benzinga.com

12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga.com

Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

benzinga.com

12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com

12 Health Care Stocks Moving In Tuesday's After-Market Session

defenseworld.net

CytoMed Therapeutics (NASDAQ:GDTC) Shares Down 11% – Here’s What Happened

CytoMed Therapeutics Limited (NASDAQ: GDTC - Get Free Report)'s stock price dropped 11% during tradi

benzinga.com

12 Health Care Stocks Moving In Monday's After-Market Session

defenseworld.net

CytoMed Therapeutics (NASDAQ:GDTC) Trading Up 7.2% – Here’s Why

CytoMed Therapeutics Limited (NASDAQ: GDTC - Get Free Report)'s stock price was up 7.2% on Thursday.

seekingalpha.com

CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript

CytoMed Therapeutics Limited (NASDAQ:GDTC ) Q2 2025 Earnings Call October 2, 2025 10:00 AM EDT Compa

globenewswire.com

CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, M

SINGAPORE, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed”

globenewswire.com

Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on it

SINGAPORE, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed”

globenewswire.com

CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program

SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed”

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

globenewswire.com

Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Further to our announcement filed on Form 6-K on Novemb

globenewswire.com

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinic

SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed”

globenewswire.com

CytoMed Therapeutics announces Chairman's Letter to the Company's shareholders

SINGAPORE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed”

benzinga.com

Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor

On Monday, CytoMed Therapeutics GDTC stock is down 6.35% at $3.23 at last check Monday.

globenewswire.com

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allo

Another Patent Granted for CytoMed's Allogeneic Induced Pluripotent Stem Cell (“iPSC”)-derived Hybri

accesswire.com

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkan

SINGAPORE / ACCESSWIRE / March 20, 2024 / CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "

globenewswire.com

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Prec

SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed”

globenewswire.com

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospit

SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed”

globenewswire.com

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Techno

The Company now has exclusive rights to a Malaysia, US and China patent The Company now has exclusiv

prnewswire.com

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technolo

SINGAPORE , Dec. 5, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "

prnewswire.com

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Conference call webcast is scheduled for November 22 at 9 a.m. ET. SINGAPORE , Nov. 17, 2023 /PRNews

prnewswire.com

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Co

SINGAPORE , Nov. 14, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or

accesswire.com

CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licens

SINGAPORE / ACCESSWIRE / October 24, 2023 / CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or

prnewswire.com

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

SINGAPORE , Sept. 25, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or